These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 27868466

  • 1. Double-blind, placebo-controlled, 1:1 randomized Phase III clinical trial of Immunoxel honey lozenges as an adjunct immunotherapy in 269 patients with pulmonary tuberculosis.
    Batbold U, Butov DO, Kutsyna GA, Damdinpurev N, Grinishina EA, Mijiddorj O, Kovolev ME, Baasanjav K, Butova TS, Sandagdorj M, Batbold O, Tseveendorj A, Chunt E, Zaitzeva SI, Stepanenko HL, Makeeva NI, Mospan IV, Pylypchuk VS, Rowe JL, Nyasulu P, Jirathitikal V, Bain AI, Tarakanovskaya MG, Bourinbaiar AS.
    Immunotherapy; 2017 Jan; 9(1):13-24. PubMed ID: 27868466
    [Abstract] [Full Text] [Related]

  • 2. Clinical validation of sublingual formulations of Immunoxel (Dzherelo) as an adjuvant immunotherapy in treatment of TB patients.
    Efremenko YV, Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Mospan IV, Pylypchuk VS, Rowe J, Jirathitikal V, Bourinbaiar AS, Kutsyna GA.
    Immunotherapy; 2012 Mar; 4(3):273-82. PubMed ID: 22401633
    [Abstract] [Full Text] [Related]

  • 3. Adjunct immune therapy of first-diagnosed TB, relapsed TB, treatment-failed TB, multidrug-resistant TB and TB/HIV.
    Butov DA, Efremenko YV, Prihoda ND, Yurchenko LI, Sokolenko NI, Arjanova OV, Stepanenko AL, Butova TS, Zaitzeva SS, Jirathitikal V, Bourinbaiar AS, Kutsyna GA.
    Immunotherapy; 2012 Jul; 4(7):687-95. PubMed ID: 22853755
    [Abstract] [Full Text] [Related]

  • 4. Adjunct oral immunotherapy in patients with re-treated, multidrug-resistant or HIV-coinfected TB.
    Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Frolov VM, Tarakanovskaya MG, Batdelger D, Jirathitikal V, Bourinbaiar AS.
    Immunotherapy; 2011 Feb; 3(2):181-91. PubMed ID: 21182457
    [Abstract] [Full Text] [Related]

  • 5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 6. Dzherelo (Immunoxel) as adjunctive therapy to standard antituberculosis treatment in patients with pulmonary tuberculosis: a systematic review and meta-analysis of clinical trials.
    Kitenge M, Phiri B, Pheeha SM, Ogunrombi M, Nyasulu PS.
    Syst Rev; 2021 May 26; 10(1):157. PubMed ID: 34039420
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy with Mycobacterium vaccae as an addition to chemotherapy for the treatment of pulmonary tuberculosis under difficult conditions in Africa.
    Onyebujoh PC, Abdulmumini T, Robinson S, Rook GA, Stanford JL.
    Respir Med; 1995 Mar 26; 89(3):199-207. PubMed ID: 7746913
    [Abstract] [Full Text] [Related]

  • 8. Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7).
    Efremenko YV, Butov DA, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, Bourinbaiar AS.
    Hum Vaccin Immunother; 2013 Sep 26; 9(9):1852-6. PubMed ID: 23782489
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of efficacy of tuberculosis drugs with Immunoxel (Dzherelo) in HIV-infected patients with active pulmonary tuberculosis.
    Arjanova OV, Prihoda ND, Yurchenko LV, Sokolenko NI, Vihrova LA, Pylypchuk VS, Frolov VM, Kutsyna GA.
    Immunotherapy; 2009 Jul 26; 1(4):549-56. PubMed ID: 20635986
    [Abstract] [Full Text] [Related]

  • 10. Randomized, placebo-controlled Phase II trial of heat-killed Mycobacterium vaccae (Immodulon batch) formulated as an oral pill (V7).
    Butov DA, Efremenko YV, Prihoda ND, Zaitzeva SI, Yurchenko LV, Sokolenko NI, Butova TS, Stepanenko AL, Kutsyna GA, Jirathitikal V, Bourinbaiar AS.
    Immunotherapy; 2013 Oct 26; 5(10):1047-54. PubMed ID: 24088075
    [Abstract] [Full Text] [Related]

  • 11. Homeopathic treatment in addition to standard care in multi drug resistant pulmonary tuberculosis: a randomized, double blind, placebo controlled clinical trial.
    Chand KS, Manchanda RK, Mittal R, Batra S, Banavaliker JN, De I.
    Homeopathy; 2014 Apr 26; 103(2):97-107. PubMed ID: 24685414
    [Abstract] [Full Text] [Related]

  • 12. Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin.
    Nikolaeva LG, Maystat TV, Pylypchuk VS, Volyanskii YL, Frolov VM, Kutsyna GA.
    Cytokine; 2008 Dec 26; 44(3):392-6. PubMed ID: 19027322
    [Abstract] [Full Text] [Related]

  • 13. Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial.
    Mwinga A, Nunn A, Ngwira B, Chintu C, Warndorff D, Fine P, Darbyshire J, Zumla A, LUSKAR collaboration.
    Lancet; 2002 Oct 05; 360(9339):1050-5. PubMed ID: 12383985
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of Mycobacterium vaccae immunotherapy for patients with tuberculosis: A systematic review and meta-analysis.
    Huang CY, Hsieh WY.
    Hum Vaccin Immunother; 2017 Sep 02; 13(9):1960-1971. PubMed ID: 28604170
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of a food supplement rich in arginine in patients with smear positive pulmonary tuberculosis--a randomised trial.
    Schön T, Idh J, Westman A, Elias D, Abate E, Diro E, Moges F, Kassu A, Ayele B, Forslund T, Getachew A, Britton S, Stendahl O, Sundqvist T.
    Tuberculosis (Edinb); 2011 Sep 02; 91(5):370-7. PubMed ID: 21813328
    [Abstract] [Full Text] [Related]

  • 20. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.
    Clin Infect Dis; 2008 Aug 15; 47(4):496-502. PubMed ID: 18611154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.